Miquel Vila complete CV
Education
1993
Licenciatura en Medicina y Cirugía (M.D.), University of Barcelona Medical School, Barcelona (Spain)
1994
Diplôme d’Etudes Approfondies (M.S.) in Neuroscience University of Paris 6, Paris (France)
1998
Docteur de l’Université de Paris 6 (Ph.D.), specialty Neuroscience, University of Paris 6, Paris (France) Sponsor: Dr. Etienne Hirsch, INSERM U289 (Prof. Yves Agid), Hôpital de la Salpétrière, Paris (France)
Present Positions
ICREA Research Professor, Catalan Institution for Research and Advanced Studies, Research Institute of the University Hospital Vall d’Hebron, Barcelona (Spain)
Adjunct Assistant Professor of Neurology, Department of Neurology, Movement Disorders Division-Neuroscience Research, Columbia University, New York (USA)
Previous appointments and positions
1993
Research Fellow, Laboratory of Neurochemistry, CSIC (Spanish National Council for Research), Barcelona (Spain)
1993-1998
Ph.D. candidate, INSERM U289, Hôpital de la Salpêtrière, Paris (France)
1998-2001
Post-doctoral Research Fellow, Department of Neurology, Movement Disorders Division-Neuroscience Research, Columbia University, New York (USA)
2001-2005
Assistant Professor of Neurology, Department of Neurology, Movement Disorders Division-Neuroscience Research, Columbia University, New York (USA)
Fellowships, Honors
1993
Fellowship from the Spanish National Council for Research (CSIC, Spain), for introduction to research
1993-1994
Fellowship from La Caixa Foundation (Beques de la Caixa, Barcelona, Spain), to pursue a D.E.A. in France
1994-1997
Fellowship (Allocation de Recherche) from the French Ministry of Education (France), to pursue a Ph.D. in France.
1998
Fellowship from the Medical Research Foundation (France)
1999-2001
Long-Term Fellowship from the Human Frontier Science Program Organization, to pursue post-doctoral training in the USA.
2005-2009
Marie Curie Excellence Grant (European Commission), to develop a new research team in Barcelona (Spain)
2006-present
Research group selected to be part of the CIBERNED (Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Spain)
Research grants as Principal Investigator
Chronic blockade of mitochondrial function and experimental models of Parkinson’s disease.
American Parkinson’s Disease Association, USA (2002-2003)
Total direct costs: $35,000
Role of Bax-dependent cell death molecular pathways in the MPTP model of Parkinson’s disease.
US Department of Defense, USA (2003-2005)
Total direct costs: $240,000
Mechanisms of Bax activation in the MPTP mouse model.
National Institutes of Health - National Institute of Aging, USA (2003-2008)
Total direct costs: $1,000,000
Caspase-3-independent programmed cell death in the MPTP mouse model of Parkinson’s Disease.
Parkinson’s Disease Foundation-National Parkinson Foundation, USA (2003-2004)
Total direct costs: $35,000
Targeting programmed cell death as a new therapeutic strategy for Parkinson's disease
Marie Curie International Reintegration Grant (Europeam Commission) (2005-2009)
Total direct costs: 80,000 €
Targeting programmed cell death in Parkinson's disease
Marie Curie Excellence Grant (European Commission) (2005-2007)
Total direct costs: 1,151,879 €
Role of mitochondrial dysfunction in Parkinson's disease
Fundació la Caixa, Spain (2006-2009)
Total direct costs: 90,000 €
